Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Edap Tms S.A. (EDAP)
NASDAQ:EDAP
EDAP Stock Chart & Stats
Day’s Range― - ―
52-Week Range$2.00 - $8.50
Previous CloseN/A
Volume29.75K
Average Volume (3M)42.28K
Market Cap
$100.92M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.45
Next Earnings
Mar 26, 2025EPS Estimate
-0.11Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.57
Shares Outstanding37,103,780
10 Day Avg. Volume43,116
30 Day Avg. Volume42,278
Standard Deviation0.16
R-Squared0.01
Alpha0.00021
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)5.05
Price to Cash Flow (P/CF)-5.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$12.00Price Target Upside341.18% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
---
EDAP TMS News
PremiumCompany Announcements
EDAP TMS Appoints Joshua H. Levine to Board of Directors
PremiumCompany Announcements
EDAP TMS Unveils Promising HIFU Study Results
---
Bulls Say, Bears Say
Bulls Say
Market AdoptionProcedure volume continues to grow, indicating continued adoption of HIFU among urologists.
Revenue GrowthEDAP reported HIFU-related revenue of €4.5M in 3Q24, a 50% YoY increase from €3.0M in 3Q23.
Bears Say
Clinical TrialsInterim results reported in July demonstrated that the study failed to meet the primary endpoint of reduced acute pelvic pain in the HIFU-treated arm compared to the Sham-treated arm at three months post-procedure.
---
Ownership Overview
19.70%
Insiders
1.49% Mutual Funds
0.08% Other Institutional Investors
78.73% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
EDAP FAQ
What was Edap Tms S.A.’s price range in the past 12 months?
Edap Tms S.A. lowest stock price was $2.00 and its highest was $8.50 in the past 12 months.
What is Edap Tms S.A.’s market cap?
Edap Tms S.A.’s market cap is $100.92M.
When is Edap Tms S.A.’s upcoming earnings report date?
Edap Tms S.A.’s upcoming earnings report date is Mar 26, 2025 which is in 32 days.
How were Edap Tms S.A.’s earnings last quarter?
Edap Tms S.A. released its earnings results on Nov 07, 2024. The company reported -$0.178 earnings per share for the quarter, missing the consensus estimate of -$0.153 by -$0.025.
Is Edap Tms S.A. overvalued?
According to Wall Street analysts Edap Tms S.A.’s price is currently Undervalued.
Does Edap Tms S.A. pay dividends?
Edap Tms S.A. does not currently pay dividends.
What is Edap Tms S.A.’s EPS estimate?
Edap Tms S.A.’s EPS estimate is -0.11.
How many shares outstanding does Edap Tms S.A. have?
Edap Tms S.A. has 37,103,780 shares outstanding.
What happened to Edap Tms S.A.’s price movement after its last earnings report?
Edap Tms S.A. reported an EPS of -$0.178 in its last earnings report, missing expectations of -$0.153. Following the earnings report the stock price went down -3.873%.
Which hedge fund is a major shareholder of Edap Tms S.A.?
Currently, no hedge funds are holding shares in EDAP
---
EDAP TMS Stock Smart Score
Company Description
Edap Tms S.A.
EDAP TMS SA is a holding company, which through its subsidiary engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology. The UDS segment focuses in the development, marketing, manufacturing, and servicing of medical devices for the minimally invasive diagnosis or treatment of urological disorders, mainly urinary stones, and other clinical indications. The company was founded on December 3, 1979 and is headquartered in Vaulx-en-Velin, France.
---
EDAP Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call revealed strong revenue growth and positive developments in the Focal One HIFU business, supported by strategic collaborations and favorable reimbursement rates. However, the company faced challenges with increased operating expenses, a higher net loss, and a decline in the LITHO business revenue. Despite these issues, the sentiment leans towards positive due to significant growth in key areas.Read More>---
EDAP Stock 12 Month Forecast
Average Price Target
$12.00
▲(341.18% Upside)
Technical Analysis
Best Analysts Covering EDAP
1 Year
1 Year Success Rate
1/11 ratings generated profit
1 Year Average Return
-31.89%
reiterated a buy rating 4 months ago
Copying Jason Bednar's trades and holding each position for 1 Year would result in 9.09% of your transactions generating a profit, with an average return of -31.89% per trade.
---